-
Je něco špatně v tomto záznamu ?
The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward
S. Lehericy, DE. Vaillancourt, K. Seppi, O. Monchi, I. Rektorova, A. Antonini, MJ. McKeown, M. Masellis, D. Berg, JB. Rowe, SJG. Lewis, CH. Williams-Gray, A. Tessitore, HR. Siebner, . ,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, přehledy
PubMed
28370449
DOI
10.1002/mds.26968
Knihovny.cz E-zdroje
- MeSH
- lidé MeSH
- magnetická rezonanční tomografie metody MeSH
- parkinsonské poruchy diagnostické zobrazování MeSH
- zobrazování trojrozměrné * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Historically, magnetic resonance imaging (MRI) has contributed little to the study of Parkinson's disease (PD), but modern MRI approaches have unveiled several complementary markers that are useful for research and clinical applications. Iron- and neuromelanin-sensitive MRI detect qualitative changes in the substantia nigra. Quantitative MRI markers can be derived from diffusion weighted and iron-sensitive imaging or volumetry. Functional brain alterations at rest or during task performance have been captured with functional and arterial spin labeling perfusion MRI. These markers are useful for the diagnosis of PD and atypical parkinsonism, to track disease progression from the premotor stages of these diseases and to better understand the neurobiological basis of clinical deficits. A current research goal using MRI is to generate time-dependent models of the evolution of PD biomarkers that can help understand neurodegeneration and provide reliable markers for therapeutic trials. This article reviews recent advances in MRI biomarker research at high-field (3T) and ultra high field-imaging (7T) in PD and atypical parkinsonism. © 2017 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.
Parkinson's Disease Research Clinic Brain and Mind Centre University of Sydney Sydney Australia
Sunnybrook Health Sciences Centre University of Toronto Toronto Ontario Canada
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17030912
- 003
- CZ-PrNML
- 005
- 20171031110826.0
- 007
- ta
- 008
- 171025s2017 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/mds.26968 $2 doi
- 035 __
- $a (PubMed)28370449
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Lehericy, Stéphane $u Institut du Cerveau et de la Moelle épinière - ICM, Centre de NeuroImagerie de Recherche - CENIR, Sorbonne Universités, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
- 245 14
- $a The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward / $c S. Lehericy, DE. Vaillancourt, K. Seppi, O. Monchi, I. Rektorova, A. Antonini, MJ. McKeown, M. Masellis, D. Berg, JB. Rowe, SJG. Lewis, CH. Williams-Gray, A. Tessitore, HR. Siebner, . ,
- 520 9_
- $a Historically, magnetic resonance imaging (MRI) has contributed little to the study of Parkinson's disease (PD), but modern MRI approaches have unveiled several complementary markers that are useful for research and clinical applications. Iron- and neuromelanin-sensitive MRI detect qualitative changes in the substantia nigra. Quantitative MRI markers can be derived from diffusion weighted and iron-sensitive imaging or volumetry. Functional brain alterations at rest or during task performance have been captured with functional and arterial spin labeling perfusion MRI. These markers are useful for the diagnosis of PD and atypical parkinsonism, to track disease progression from the premotor stages of these diseases and to better understand the neurobiological basis of clinical deficits. A current research goal using MRI is to generate time-dependent models of the evolution of PD biomarkers that can help understand neurodegeneration and provide reliable markers for therapeutic trials. This article reviews recent advances in MRI biomarker research at high-field (3T) and ultra high field-imaging (7T) in PD and atypical parkinsonism. © 2017 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a zobrazování trojrozměrné $7 D021621
- 650 _2
- $a magnetická rezonanční tomografie $x metody $7 D008279
- 650 _2
- $a parkinsonské poruchy $x diagnostické zobrazování $7 D020734
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Vaillancourt, David E $u Department of Applied Physiology and Kinesiology, Department of Neurology and Centre for Movement Disorders and Neurorestoration, Department of Biomedical Engineering, University of Florida, Gainesville, Florida, USA.
- 700 1_
- $a Seppi, Klaus $u Department of Neurology, Medical University Innsbruck, Innsbruck, Austria and Neuroimaging Research Core Facility, Medical University Innsbruck, Innsbruck, Austria.
- 700 1_
- $a Monchi, Oury $u Department of Clinical Neurosciences, Department of Radiology, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
- 700 1_
- $a Rektorova, Irena $u First Department of Neurology, School of Medicine, St. Anne's University Hospital, Brain and Mind Research Program, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Antonini, Angelo $u Parkinson and Movement Disorders Unit, istituto di ricovero e cura a carattere scientifico (IRCCS) Hospital San Camillo, Venice and Department of Neurosciences (DNS), Padova University, Padova, Italy. $7 gn_A_00007450
- 700 1_
- $a McKeown, Martin J $u Pacific Parkinson's Research Center, Department of Medicine (Neurology), University of British Columbia Vancouver, BC, Canada.
- 700 1_
- $a Masellis, Mario $u Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
- 700 1_
- $a Berg, Daniela $u Department of Neurology, Christian-Albrechts-University of Kiel and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.
- 700 1_
- $a Rowe, James B $u Department of Clinical Neurosciences, Cambridge University, and Medical Research Council Cognition and Brain Sciences Unit, Cambridge, UK.
- 700 1_
- $a Lewis, Simon J G $u Parkinson's Disease Research Clinic, Brain and Mind Centre, University of Sydney, Sydney, Australia.
- 700 1_
- $a Williams-Gray, Caroline H $u John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
- 700 1_
- $a Tessitore, Alessandro $u Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, Second University of Naples, Naples, Italy.
- 700 1_
- $a Siebner, Hartwig R $u Danish Research Centre for Magnetic Resonance, Centre for Functional and Diagnostic Imaging and Research, Copenhagen University Hospital Hvidovre, Department of Neurology, Copenhagen University Hospital Bispebjerg, Hvidovre, Denmark.
- 700 1_
- $a ,
- 773 0_
- $w MED00003420 $t Movement disorders official journal of the Movement Disorder Society $x 1531-8257 $g Roč. 32, č. 4 (2017), s. 510-525
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28370449 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20171025 $b ABA008
- 991 __
- $a 20171031110916 $b ABA008
- 999 __
- $a ok $b bmc $g 1254505 $s 991939
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 32 $c 4 $d 510-525 $e 20170328 $i 1531-8257 $m Movement disorders $n Mov Disord $x MED00003420
- LZP __
- $a Pubmed-20171025
